Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BZ | MORN |
|---|---|---|
| Price | $15.10 | $189.16 |
| Change today | ▲ 1.82% | ▲ 3.06% |
| Market cap | $7.10B | $7.10B |
| Return, 3 months | +11.7% | +11.3% |
| Return, year to date | -23.1% | -12.0% |
| Return, 1 year | -35.2% | -14.5% |
| P/E (TTM) | 10.3 | 18.0 |
| P/B | 2.3 | 6.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.17% | 1.03% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 53 | 43 |
| 30-day volatility | 60.4% | 37.5% |
| Max drawdown, 1 year | -48.1% | -39.7% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
